The debate over whether the University of California should restore the SAT in admissions, expected to surface next week before regents, is emerging as one of its ...
Morning Overview on MSN
A breast-cancer drug slowed tumors in a trial of hard-to-treat patients
Patients with triple-negative breast cancer who cannot receive immunotherapy now have a new first-line treatment option after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results